Relaxation-compensated APT and rNOE CEST-MRI of human brain tumors at 3 T.

CONCLUSION: The presented acquisition protocol allows relaxation-compensated CEST-MRI at 3 T with a 3D coverage of the human brain. Translation to a clinically relevant magnetic field strength of 3 T opens the door to trials with a large number of participants, thus enabling a comprehensive assessment of the clinical relevance of relaxation compensation in CEST-MRI. PMID: 30927313 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30927313?dopt=Abstract

Source: Magnetic Resonance in Medicine - March 28, 2019 Category: Radiology Authors: Goerke S, Soehngen Y, Deshmane A, Zaiss M, Breitling J, Boyd PS, Herz K, Zimmermann F, Klika KD, Schlemmer HP, Paech D, Ladd ME, Bachert P Tags: Magn Reson Med Source Type: research